ArticleJournal of radiation oncology2018
Stereotactic radiosurgery practice patterns for brain metastases in the United States: a national survey.
Article in Journal of radiation oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.
- Pooled it
- Overall survival following stereotactic radiosurgery for ten or more brain metastases: a systematic review and meta-analysis.BMC cancer · 2023Pooled it
- Article
- Control-point-specific plan robustness in volumetric modulated arc therapy-based cranial radiotherapy.Journal of applied clinical medical physics · 2026Article
- Evaluation of the efficacy and safety of HyperArc stereotactic radiotherapy for the treatment of lung cancer brain metastasis.Medical oncology (Northwood, London, England) · 2025Article
- Stereotactic radiosurgery practice patterns for brain metastases: a survey by the SRS_SBRT_SEOR (Spanish Society of Radiation Oncology) Working Group.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025Article
- Evaluation of artificial intelligence and optical image recognition techniques used in OneIso, an off-axis Winston-Lutz quality assurance phantom.Biomedical physics & engineering express · 2024Article
- Dosimetric evaluation of LINAC-based single-isocenter multi-target multi-fraction stereotactic radiosurgery with more than 20 targets: comparing MME, HyperArc, and RapidArc.Radiation oncology (London, England) · 2024Article
- A multi-institutional trial evaluating the use of an integrated quality assurance phantom for frameless single-isocenter multitarget stereotactic radiosurgery.Frontiers in oncology · 2024Article
- Cystic Brain Metastasis Outcomes After Gamma Knife Radiation Therapy.Advances in radiation oncology · 2024Article
- Comparison of the accuracy of Monte Carlo and Ray Tracing dose calculation algorithms for multiple target brain treatments on CyberKnife.Physical and engineering sciences in medicine · 2023Article
- Region-of-interest intra-arc MV imaging to facilitate sub-mm positional accuracy with minimal imaging dose during treatment deliveries of small cranial lesions.Journal of applied clinical medical physics · 2022Article
- Recent Advances and Applications of Radiation Therapy for Brain Metastases.Current oncology reports · 2022Review
- Simultaneous radiosurgery for multiple brain metastases: technical overview of the UCLA experience.Radiation oncology (London, England) · 2021Article
- Frame-based radiosurgery of multiple metastases using single-isocenter volumetric modulated arc therapy technique.Journal of applied clinical medical physics · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
backgroundStereotactic radiosurgery (SRS) has emerged as an important modality for the treatment of intracranial metastases. There are currently few established guidelines delineating indications for SRS use and fewer still regarding plan evaluation in the treatment of multiple brain metastases.
methodsAn 18 question electronic survey was distributed to radiation oncologists at National Cancer Institute (NCI) designated cancer centers in the USA (60). Centers without radiation oncologists were excluded. Physicians who indicated that they do not prescribe SRS were excluded from the remaining survey questions. Sign test and Chi-square test were used to determine if responses differed significantly from random distribution.
resultsOne hundred sixteen of the 697 radiation oncologists surveyed completed the questionnaire, representing 51 institutions. Sixty-two percent reported treating patients with brain metastases using SRS. Radiation oncologists prescribing SRS most commonly treat CNS (66.2%) and lung (49.3%) malignancies. SRS was used more frequently for < 10 brain metastases (73.7%;
conclusionsThis is one of the first national surveys assessing the use of SRS for brain metastases in clinical practice. These data highlight some clinical considerations for physicians treating brain metastases with SRS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.